A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1



Status:Recruiting
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:3/30/2013
Start Date:July 2009
End Date:August 2017
Contact:Pfizer CT.gov Call Center
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

A Phase 2b Open-Label Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 Infected Subjects


The purpose of the protocol is to assess long-term safety and tolerability of subjects who
discontinue for any reason from UK-453,061 qualifying studies.


To assess long term safety and tolerability of subjects who discontinue for any reason from
UK-453,061 studies. The study will also assess efficacy of the subsequent regimens in these
patients.

Inclusion Criteria:

- Previous participation in a qualifying study.

- Male or female at least 18 years of age available for a follow-up period of at least
96 weeks.

Exclusion Criteria:

- Concurrent treatment in another clinical trial.

- Unwilling or unable to be followed for 12 months
We found this trial at
5
sites
Atlantis, Florida 33462
?
mi
from
Atlantis, FL
Click here to add this to my saved trials
Akron, Ohio 44314
?
mi
from
Akron, OH
Click here to add this to my saved trials
Atlanta, Georgia 30309
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials